Autonomix Medical (AMIX) Liabilities and Shareholders Equity (2023 - 2026)

Autonomix Medical (AMIX) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $10.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 14.57% year-over-year to $10.2 million; the TTM figure through Dec 2025 stood at $36.9 million (up 9.23% YoY), while the FY2025 annual figure was $9.8 million, up 4.24% from the prior year.
• Liabilities and Shareholders Equity advanced to $10.2 million in Q4 2025 per AMIX's latest filing, from $7.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $12.0 million in Q4 2024 and bottomed at $865000.0 in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $7.3 million across 3 years, with a median of $8.5 million in 2025.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity soared 987.51% — and 2025, when it retreated 14.57%.
• Autonomix Medical's Liabilities and Shareholders Equity stood at $1.8 million in 2023, then surged by 560.7% to $12.0 million in 2024, then slipped by 14.57% to $10.2 million in 2025.
• Business Quant data shows AMIX's Liabilities and Shareholders Equity at $10.2 million in Q4 2025, $7.9 million in Q3 2025, and $9.0 million in Q2 2025.